A virus‐derived microRNA targets immune response genes during SARS‐CoV‐2 infection - Archive ouverte HAL Access content directly
Journal Articles EMBO Reports Year : 2021

A virus‐derived microRNA targets immune response genes during SARS‐CoV‐2 infection

Abstract

SARS-CoV-2 infection results in impaired interferon response in patients with severe COVID-19. However, how SARS-CoV-2 interferes with host immune responses is incompletely understood. Here, we sequence small RNAs from SARS-CoV-2-infected human cells and identify a microRNA (miRNA) derived from a recently evolved region of the viral genome. We show that the virus-derived miRNA produces two miRNA isoforms in infected cells by the enzyme Dicer, which are loaded into Argonaute proteins. Moreover, the predominant miRNA isoform targets the 3'UTR of interferon-stimulated genes and represses their expression in a miRNA-like fashion. Finally, the two viral miRNA isoforms were detected in nasopharyngeal swabs from COVID-19 patients. We propose that SARS-CoV-2 can potentially employ a virus-derived miRNA to hijack the host miRNA machinery, which could help to evade the interferon-mediated immune response.
Fichier principal
Vignette du fichier
EMBO Reports - 2021 - Singh - A virus%u2010derived microRNA targets immune response genes during SARS%u2010CoV%u20102 infection.pdf (1.06 Mo) Télécharger le fichier

Dates and versions

pasteur-03514377 , version 1 (06-01-2022)

Licence

Attribution - CC BY 4.0

Identifiers

Cite

Meetali Singh, Maxime Chazal, Piergiuseppe Quarato, Loan Bourdon, Christophe Malabat, et al.. A virus‐derived microRNA targets immune response genes during SARS‐CoV‐2 infection. EMBO Reports, 2021, pp.e54341. ⟨10.15252/embr.202154341⟩. ⟨pasteur-03514377⟩
94 View
261 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More